» Articles » PMID: 48003

Metronidazole for Crohn's Disease

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1975 Apr 5
PMID 48003
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Five patients with Crohn's disease for 4 months to 12 years were treated with metronidazole. Four of them improved after 2-4 weeks' treatment. In three of them corticosteroids and sulphasalazine could be withdrawn. One patient did not improve until 4 months of metronidazole treatment had passed and corticosteroids were reintroduced. In three patients metronidazole was discontinued after 4-6 months of treatment. Two of them had no signs or symptoms of relapse 3 and 6 months later. The third patient is free from symptoms but laboratory data indicate disease activity.

Citing Articles

A review of the therapeutic management of Crohn's disease.

Kumar A, Cole A, Segal J, Smith P, Limdi J Therap Adv Gastroenterol. 2022; 15:17562848221078456.

PMID: 35198041 PMC: 8859667. DOI: 10.1177/17562848221078456.


Role of bacteria in the etiopathogenesis of inflammatory bowel disease.

Barnich N, Darfeuille-Michaud A World J Gastroenterol. 2007; 13(42):5571-6.

PMID: 17948930 PMC: 4172735. DOI: 10.3748/wjg.v13.i42.5571.


Antibiotic therapy for Crohn's disease: a review.

Lal S, Steinhart A Can J Gastroenterol. 2006; 20(10):651-5.

PMID: 17066156 PMC: 2660793. DOI: 10.1155/2006/250490.


Prevention of postoperative recurrence in Crohn's disease.

DHaens G Curr Gastroenterol Rep. 2000; 1(6):476-81.

PMID: 10980989 DOI: 10.1007/s11894-999-0006-6.


Risk factors for surgery and postoperative recurrence in Crohn's disease.

Bernell O, Lapidus A, Hellers G Ann Surg. 2000; 231(1):38-45.

PMID: 10636100 PMC: 1420963. DOI: 10.1097/00000658-200001000-00006.